Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SYRE | RGEN | KYMR | ||
| Company | Spyre Therapeutics Inc | Repligen Corp | Kymera Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 106.01 | 159.44 | 106.61 | ||
| High | 106.67 | 164.97 | 108.12 | ||
| Low | 103.64 | 159.44 | 104.78 | ||
| Last | 104.91 | 163.90 | 107.52 | ||
| Change | +1.49 | +4.46 | +1.11 | ||
| Percent Change | +1.44% | +2.80% | +1.04% | ||
| Volume | 526,500 | 950,400 | 463,500 | ||
| 20-Day Average Volume | 999,465 | 1,341,950 | 560,105 | ||
| Previous | 103.42 | 159.44 | 106.41 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 100.03 | 145.45 | 108.90 | ||
| 20-Day Raw Stochastic | 79.52% | 97.03% | 39.39% | ||
| 20-Day Relative Strength | 59.19 | 66.15 | 53.44 | ||
| Weighted Alpha | +462.71 | +47.34 | +121.53 | ||
| Today's Opinion | 100% Buy | 72% Buy | 80% Buy | ||
| Yesterday's Opinion | 100% Buy | 72% Buy | 80% Buy | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.69% since 07/31/26 | +16.23% since 07/31/26 | +3.98% since 07/31/26 | ||
| Low | 92.71 on 08/03/26 | 140.54 on 08/03/26 | 99.52 on 08/03/26 | ||
| High | 108.14 on 08/05/26 | 164.97 on 08/07/26 | 108.12 on 08/07/26 | ||
| 1-Month | |||||
| %Chg | +11.33% since 07/07/26 | +17.21% since 07/07/26 | -9.83% since 07/07/26 | ||
| Low | 90.64 on 07/08/26 | 129.00 on 07/21/26 | 99.52 on 08/03/26 | ||
| High | 108.14 on 08/05/26 | 164.97 on 08/07/26 | 120.60 on 07/10/26 | ||
| 3-Month | |||||
| %Chg | +43.52% since 05/07/26 | +29.64% since 05/07/26 | +27.05% since 05/07/26 | ||
| Low | 64.67 on 05/19/26 | 100.99 on 05/14/26 | 69.48 on 06/03/26 | ||
| High | 108.14 on 08/05/26 | 164.97 on 08/07/26 | 130.05 on 06/25/26 | ||
| 6-Month | |||||
| %Chg | +198.72% since 02/06/26 | +15.28% since 02/06/26 | +35.09% since 02/06/26 | ||
| Low | 32.35 on 02/11/26 | 100.99 on 05/14/26 | 69.48 on 06/03/26 | ||
| High | 108.14 on 08/05/26 | 164.97 on 08/07/26 | 130.05 on 06/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,225,365 | 9,249,860 | 8,940,396 | ||
| Shares Outstanding, K | 87,936 | 56,436 | 83,151 | ||
| Annual Sales, $M | 0 | 738,260,000 | 39,210,000 | ||
| Annual Net Income, $M | -155,200,000 | 48,890,000 | -311,350,000 | ||
| Last Qtr Sales, $M | 0 | 204,130,000 | 34,370,000 | ||
| Last Qtr Income, $M | -69,010,000 | 5,010,000 | -69,230,000 | ||
| 60-Month Beta | 3.03 | 1.03 | 1.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.36 on 08/04/26 | 0.54 on 07/28/26 | -0.62 on 08/05/26 | ||
| Latest Earnings Date | 11/03/26 | 10/27/26 | 11/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 80.93 | 0.00 | ||